Invention Grant
- Patent Title: PPAR-sparing compounds for the treatment of metabolic diseases
- Patent Title (中): 用于治疗代谢疾病的PPAR保留化合物
-
Application No.: US14906686Application Date: 2014-07-21
-
Publication No.: US09562012B2Publication Date: 2017-02-07
- Inventor: Steven P. Tanis , Scott D. Larsen , Gerald D. Artman, III , Timothy Parker
- Applicant: Metabolic Solutions Development Company, LLC
- Applicant Address: US MI Kalamazoo
- Assignee: Metabolic Solutions Development Company, LLC
- Current Assignee: Metabolic Solutions Development Company, LLC
- Current Assignee Address: US MI Kalamazoo
- Agency: Honigman Miller Schwartz & Cohn LLP
- Agent Andrew N. Weber; Jonathan P. O'Brien
- International Application: PCT/US2014/047411 WO 20140721
- International Announcement: WO2015/013187 WO 20150129
- Main IPC: A61K31/085
- IPC: A61K31/085 ; A61K31/165 ; A61K31/33 ; C07D213/68 ; C07C259/06 ; C07C309/66 ; C07C317/22 ; C07D213/30 ; A61K31/44 ; A61K31/4402 ; A61K45/06

Abstract:
The present invention relates to hydroxamate compounds and pharmaceutical compositions that are useful for treating and/or preventing metabolic inflammation mediated diseases such as diabetes, obesity, hypertension, dyslipidemia, a neurodegenerative disorder (e.g., Alzheimer's disease, Parkinson's disease, or Huntington's disease), or any combination thereof. Moreover, the present invention also provides methods of treatment for these diseases or disorders.
Public/Granted literature
- US20160152570A1 PPAR-SPARING COMPOUNDS FOR THE TREATMENT OF METABOLIC DISEASES Public/Granted day:2016-06-02
Information query